Skip to main content

Table 5 Interaction between Caveolin 1 genotypes and dietary fat types with fat distribution

From: The interactions between dietary fats intake and Caveolin 1 rs 3807992 polymorphism with fat distribution in overweight and obese women: a cross-sectional study

  FM (kg) p value Visceral fat level (cm2) p value Trunk fat (kg) p value WC (cm) p value
B CI B CI B CI B CI
Crude             
Total fat*AA 0.02 − 0.96, 0.13 0.73 0.11 − 0.01, 0.04 0.86 0.02 − 0.00, 0.05 0.76 0.09 − 0.00, 0.18 0.19
Total fat*AG − 0.00 − 0.12, 0.10 0.90 0.17 − 0.05, 0.00 0.05 0.00 0.05, 0.06 0.83 0.02 − 0.10, 0.15 0.66
Adjusted             
Total fat*AA 0.56 − 4.36, 5.5 0.82 14.78 5.71, 23.78 0.001 8.53 6.20, − 3.61 0.01 0.00 − 0.06, 0.08 0.05
Total fat*AG 1.73 − 4.27, 7.74 0.57 7.53 − 7.20, 21.90 0.05 3.00 7.76, − 12.22 0.14 0.07 − 0.00, 0.14 0.08
Crude             
SFA*AA 0.12 − 0.00, 0.18 0.15 0.04 0.08, 1.13 0.33 0.05 − 0.03, 0.14 0.23 0.17 − 0.02,0.36 0.04
SFA*AG 0.06 0.08, 0.04 0.53 0.03 0.12, 0.01 0.28 − 0.04 − 0.15, 0.06 0.41 0.17 0.40,0.04 0.15
Adjusted             
SFA*AA 0.009 − 0.01, 0.05 0.72 0.05 − 0.58, 0.69 0.87 0.03 − 0.00, 0.07 0.06 0.08 − 0.42, 0.59 0.40
SFA*AG 0.04 0.18, 1.98 0.15 0.23 − 0.58, 1.04 0.57 − 0.02 − 0.07, 0.02 0.30 0.17 − 0.75, 0.39 0.10
Crude             
TFA*AA 101.72 − 1207.75, − 1.55 0.83 193.98 − 183.48, 571.44 0.31 82.87 − 325.99, 517.64 0.69 589.33 − 480.02, 1658.70 0.28
TFA*AG 175.09 − 879.14, 1082.59 0.89 393.89 − 620.30, 1408.09 0.44 66.45 − 1275.74, 1339.71 0.92 274.63 − 2594.84, 3144.10 0.85
Adjusted             
TFA*AA 649.22 397.61, 1696.05 0.22 34.29 − 46.25, 382.84 0.08 80.62 − 128.56, 94.47 0.36 556.93 − 476.72, 1590.59 0.09
  3.59 − 14.31, 21.50 0.69 3.10 − 3.24, 9.44 0.33       
TFA*AG 119.07 − 217.26, 455.41 0.48 168.84 − 632.04, 701.72 0.01 190.48 − 357.07, 738.04 0.49 652.71 − 2573.60, 387,903 0.69
  0.04 9.57 − 10.22, 29.37 0.34         
Crude             
MUFA*AA 0.15 − 0.01, 0.32 0.07 0.05 0.12, 2.56 0.10 0.07 − 0.01, 0.16 0.11 0.21 0.40, 4.70 0.03
MUFA*AG − 0.00 − 0.17,0.16 0.96 0.00 − 0.06, 0.06 0.97 − 0.01 − 0.1, 0.09 0.85 − 0.04 − 0.22, 0.13 0.62
Adjusted             
MUFA*AA 0.02 − 0.36, 0.34 0.48 0.03 − 0.02, 0.08 0.22 0.03 − 0.00, 0.07 0.10 0.06 − 0.35, 0.47 0.36
MUFA*AG 0.00 − 0.00, 0.36 0.86 − 0.02 − 0.08, 0.02 0.30 − 0.01 − 0.06, 0.02 0.58 − 0.06 − 0.49, 0.39 0.33
Crude             
PUFA*AA 0.11 − 0.12, 0.36 0.34 0.06 − 0.03, 0.15 0.19 0.07 − 0.04, 0.19 0.24 0.18 − 0.08, 0.46 0.17
PUFA*AG 0.03 − 0.26, 0.19 0.04 0.00 − 0.08, 0.08 0.98 0.00 − 0.13, 0.13 0.98 − 0.07 0.17, 0.34 0.55
Adjusted             
PUFA*AA 0.06 − 0.39, 0.17 0.21 0.06 − 0.00, 0.13 0.06 0.04 − 0.01, 0.09 0.60 0.00 − 1.17, 0.17 0.62
PUFA*AG 0.01 − 0.10, 0.12 0.85 − 0.02 − 0.10, 0.04 0.46 − 0.01 − 0.07, 0.05 0.15 − 0.07 0.11, 0.59 0.98
Crude             
EPA and DHA*AA 6.41 − 12.2, 25.02 0.50 3.19 − 3.83, 10.22 0.37 1.28 − 10.02, 12.59 0.82 9.16 − 11.45, 29.79 0.38
EPA and DHA*AG 6.20 − 14.26, 26.68 0.55 3.45 − 4.26, 11.17 0.38 7.75 − 3.29, 18.80 0.16 5.32 − 17.35, 28.01 0.64
Adjusted             
EPA and DHA*AA 3.7 − 1.5, 9.02 0.16 1.85 − 9.63, 11.84 0.27 1.60 − 1.78, 2.13 0.25 4.89 − 3.61, 13.39 0.25
EPA and DHA*AG 2.37 − 3.71, 8.46 0.44 3.00 − 2.57, 18.49 0.12 1.59 − 1.43, 2.47 0.32 1.4 − 8.37, 11.26 0.77
Crude             
linoleic acid*AA − 0.11 − 0.44, 0.21 0.49 0.01 − 0.11, 0.14 0.81 0.06 − 0.05, 0.19 0.28 0.10 − 0.27, 0.48 0.58
linoleic acid*AG − 0.29 − 0.57, − 0.00 0.04 − 0.09 − 2.02, 0.01 0.10 0.01 − 0.11, 0.15 0.82 − 0.31 − 0.63, 0.01 0.05
Adjusted             
linoleic acid*AA 0.05 − 0.05, 0.16 0.31 0.06 − 0.01, 0.13 0.10 0.03 − 0.03, 0.10 0.27 − 0.01 0.16, 0.03 0.91
linoleic acid*AG 0.02 − 1.00, − 0.14 0.73 − 0.02 − 0.10, 0.05 0.52 0.00 − 0.07, 0.07 0.81 − 0.06 − 0.26, 0.12 0.48
Crude             
ALA*AA − 2.97 − 8.43, 2.49 0.28 − 0.99 − 3.12, 1.14 0.36 − 0.01 − 2.85, 2.83 0.99 − 0.87 − 7.01, 5.26 0.78
ALA*AG − 3.34 − 7.31, 0.64 0.10 − 1.21 2.75, 0.32 0.12 − 1.39 − 3.65, 0.86 0.22 − 1.23 − 3.19, 5.66 0.58
Adjusted             
ALA*AA − 1.23 − 8.50, 6.04 0.74 − 0.81 − 3.91, 2.27 0.60 0.68 − 0.44, 1.81 0.23 − 0.55 − 6.17, 5.06 0.84
ALA*AG − 3.96 − 10.49, 2.55 0.10 − 2.43 − 5.15, 0.29 0.12 − 0.38 − 1.40, 0.63 0.22 − 1.74 − 6.79, 3.29 0.58
  HC (cm) p value WHR p value WHtR p value
B CI B CI B CI
Crude          
Total fat*AA 0.02 − 0.08, 0.04 0.69 0.00 − 0.05, 0.06 0.99 0.00 0.00, 0.001 0.81
Total fat*AG 0.01 − 0.08, 0.13 0.78 − 0.004 − 0.11, − 0.00 0.90 0.00 − 0.00, 0.00 0.92
Adjusted          
Total fat*AA 3.66 0.03, 4.50 0.98 0.00 − 0.00, 0.00 0.46 0.00 0.00, 0.01 0.89
Total fat*AG 0.01 − 0.01, 0.04 0.32 0.00 − 0.00, 0.00 0.02 0.00 0.00, 0.00 0.30
Crude          
SFA*AA 0.05 − 0.11, 0.22 0.17 0.00 − 0.09, 0.1 0.95 0.00 −  0.17, 0.17 0.98
SFA*AG 0.06 − 0.14, 0.28 0.52 − 0.08 − 0.20, 0.04 0.18 − 0.00 0.00, 3.00 0.06
Adjusted          
SFA*AA 0.07 − 0.25, 0.40 0.59 0.00 − 0.00, 0.00 0.83 0.00 − 0.00, 0.00 0.55
SFA*AG 0.02 − 0.40, 0.35 0.73 0.00 − 0.00, 0.00 0.34 0.00 − 0.00, 0.00 0.18
Crude          
TFA*AA 23.86 − 931.24, 978.96 0.96 7.46 − 990.14, 1005.06 0.98 3.16 − 3.35, 9.69 0.34
TFA*AG 625.73 − 1937.12, 3188.59 0.63 5.12 − 5622.95, 1664.13 0.28 8.63 − 8.87, 26.13 0.33
Adjusted          
TFA*AA 38.07 − 647.26, 723.30 0.91       
TFA*AG 324.55 − 1814.39, 2463.49 0.76 4.84 − 0.88, 10.57     
Crude          
MUFA*AA 0.07 − 0.37, 0.41 0.37 0.00 − 0.09, 0.09 0.96 0.00 − 0.00, 0.00 0.14
MUFA*AG 0.11 0.25, 1.13 0.17 − 0.08 − 0.17, − 0.01 0.06 0.00 − 0.00, 0.001 0.40
Adjusted          
MUFA*AA 0.02 − 0.24, 0.29 0.85 0.00 − 0.00, 0.00 0.64 0.00 0.00, 0.00 0.94
MUFA*AG 0.03 − 0.25, 0.32 0.80 0.00 − 0.00, 0.00 0.04 0.00 − 0.00, 0.00 0.29
Crude          
PUFA*AA 0.06 − 0.17, 0.07 0.60 − 0.00 − 0.13, 0.13 0.98 0.00 − 0.00, 0.00 0.01
PUFA*AG 0.16 − 0.21, 0.37 0.13 − 0.14 − 0.26, − 0.01 0.02 − 0.00 − 0.00, 0.00 0.11
Adjusted          
PUFA*AA 0.01 − 0.43,0.23 0.46 0.00 − 0.00, 0.00 0.66 0.00 − 0.00, 0.00 0.56
PUFA*AG − 0.01 − 0.00, 0.00 0.65 − 0.00 − 0.00, 0.00 0.32 − 0.00 − 0.00, 0.00 0.83
Crude          
EPA and DHA*AA 2.42 − 17.18, 22.02 0.80 0.03 − 13.00, 13.07 0.99 0.06 − 0.05, 0.19 0.28
EPA and DHA*AG 13.26 − 6.05, 32.58 0.17 6.38 − 7.95, 20.72 0.38 0.04 − 0.09, 0.17 0.53
Adjusted          
EPA and DHA*AA − 0.07 − 3.69, 3.53 0.96 0.04 − 0.03, 0.12 0.25 0.01 − 0.2, 0.04 0.50
EPA and DHA*AG 0.43 − 3.74, 4.60 0.83 0.01 − 0.07, 0.10 0.76 0.02 − 0.02, 0.06 0.33
Crude          
linoleic acid*AA − 0.10 − 0.43, 0.23 0.55 0.00 − 0.23, 0.23 0.99 0.00 − 0.00, 0.00 0.64
linoleic acid*AG − 0.11 − 0.48, 0.25 0.55 − 0.21 − 0.42, − 0.01 0.03 − 0.00 − 0.00, 0.00 0.01
Adjusted          
linoleic acid*AA 0.01 − 0.09, 0.07 0.78 0.00 − 0.00, 0.00 0.81 0.00 − 0.00, 0.00 0.83
linoleic acid*AG − 0.12 − 0.07, 0.07 0.78 − 0.00 − 0.00, 0.00 0.04 0.00 − 0.00, 0.00 0.37
Crude          
ALA*AA − 0.87 − 7.01, 5.26 0.78 − 0.01 − 3.89, 3.93 0.99 0.00 − 0.03, 0.03 0.99
ALA*AG − 1.23 − 3.19, 5.66 0.58 − 2.50 − 5.35, 0.34 0.06 − 0.03 − 0.05, − 0.00 0.03
Adjusted          
ALA*AA − 0.55 − 6.17, 5.06 0.84 − 0.00 − 0.05, 0.04 0.76 − 0.02 − 0.07, 0.02 0.39
ALA*AG − 1.74 − 6.79, 3.29 0.58 − 0.04 − 0.08, 0.00 0.06 − 0.04 − 0.09, − 0.00 0.07
  1. All data are presented as B ± CI obtained from Generalized Linear Models
  2. p value *: Adjusted for age, BMI, energy intake, and physical activity
  3. p value < 0.05 was considered significant
  4. FM fat mass, WC waist circumference, HC hip circumference, WHR weight to hip ratio, WHtR weight to height ratio, SFA saturated fatty acid, TFA trans-fatty acid, MUFA monounsaturated fatty acid, PUFA polyunsaturated fatty acid, EPA-DHA: eicosapentaenoic acid and docosahexaenoic acid, ALA alpha-linolenic acid